Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Validation of a Digital Caries Risk Assessment Questionnaire Against the CAMBRA Protocol in an Egyptian Adult Population

15 luglio 2026 aggiornato da: Shereen Assem, October University for Modern Sciences and Arts

Validation of a Digital Caries Risk Assessment Questionnaire Against the CAMBRA Protocol in an Egyptian Adult Population: A Cross-Sectional Diagnostic Agreement Study

This study is designed as a cross-sectional diagnostic agreement study conducted in accordance with the Standards for Reporting Diagnostic Accuracy Studies (STARD 2015) and the Guidelines for Reporting Agreement and Precision of Patient-reported Assessments (GRAPPA). The study evaluates the diagnostic agreement between the Digital Caries Risk Questionnaire (DCRQ), a novel patient self-administered digital instrument, and the Caries Management by Risk Assessment (CAMBRA) protocol as the primary clinical comparator. The Decayed, Missing, and Filled Teeth (DMFT) index is used as the reference standard for cumulative caries experience, with a threshold of DMFT ≥ 4 to identify individuals with high caries experience. Although the DMFT index reflects previous disease experience rather than future disease risk, it provides an objective clinical outcome for assessing construct validity. Accordingly, CAMBRA serves as the primary comparator for risk classification, whereas the DMFT index supports validation by evaluating the relationship between questionnaire-derived risk categories and cumulative clinical disease burden.

The methodological rationale for this study is based on the current evidence supporting contemporary caries risk assessment models. CAMBRA is recognized as one of the most extensively validated and widely implemented caries risk assessment systems and has demonstrated diagnostic performance comparable to other internationally accepted risk assessment models. Systematic evidence has shown that these validated models provide acceptable discriminatory ability and calibration for identifying individuals at increased risk of developing dental caries. Furthermore, recent evidence synthesizing longitudinal cohort studies has identified a consistent set of adult caries risk factors, including smoking, systemic diseases, water fluoridation exposure, educational level, fluoride toothpaste use, dietary sugar intake, bacterial plaque accumulation, and previous caries experience. These established determinants are comprehensively represented within the nine domains of the DCRQ, supporting its content validity. In addition, previous validation studies of simplified questionnaire-based caries risk assessment instruments have demonstrated acceptable internal consistency, good test-retest reliability, and significant associations between increasing risk categories and objective clinical indicators such as DMFT scores, plaque accumulation, white spot lesions, and active cavitated lesions. Collectively, these findings support the use of a cross-sectional diagnostic agreement design in which questionnaire-derived risk classification is evaluated against an established clinical risk assessment protocol and validated using objective measures of cumulative caries experience.

Panoramica dello studio

Stato

Reclutamento

Tipo di studio

Osservativo

Iscrizione (Stimato)

384

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

  • Nome: Nermeen Kamal Hamza, Professor
  • Numero di telefono: +201211110660
  • Email: nhamza@msa.edu.eg

Luoghi di studio

    • Sixth of October
      • Giza, Sixth of October, Egitto, 12566
        • Reclutamento
        • October university for modern sciences and arts
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Metodo di campionamento

Campione di probabilità

Popolazione di studio

The study will be conducted at the Dental Outpatient Clinic, Faculty of Dentistry, MSA University (October University for Modern Sciences and Arts), 6th October City, Cairo, Egypt. Consecutive sampling will be employed on designated study days to minimise selection bias, consistent with STARD 2015 recommendations for diagnostic accuracy studies.

Descrizione

  • Inclusion Criteria

    1. Adults aged 18 to 65 years.
    2. Egyptian nationals or individuals who have resided in Egypt for at least 5 years.
    3. Able to read and understand Arabic or English.
    4. Presence of at least 10 natural teeth.
    5. Presenting for routine dental examination, preventive care, or treatment planning.
    6. Able and willing to provide written informed consent.
  • Exclusion Criteria

    1. Presence of acute dental pain or a dental emergency requiring immediate treatment at the time of enrollment.
    2. Severe cognitive impairment or psychiatric disorder that would interfere with completion of the questionnaire or informed consent.
    3. Currently participating in another oral health research study.
    4. Complete edentulism or extensive fixed prosthetic rehabilitation that precludes assessment of the Decayed, Missing, and Filled Teeth (DMFT) index.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Digital caries risk assessment
The Digital Caries Risk Questionnaire (DCRQ) is a patient self-administered digital instrument encompassing nine weighted risk domains: (1) disease indicators and dental history; (2) dietary and lifestyle habits; (3) oral hygiene practices and fluoride use; (4) salivary and gingival health; (5) medical conditions; (6) current medications; (7) water source and fluoride exposure; (8) tobacco and nicotine use; and (9) clinical symptoms. Each domain generates a weighted subscore; domain scores are summed to yield a total score (maximum 160 points), with predefined override rules applied to prevent underestimation of risk in participants presenting with strong disease indicators (e.g., multiple restorations, root canal treatments, or persistent dental pain), ensuring clinically appropriate classification regardless of total score. The total score maps to one of four ordered risk categories: Low (0-39), Moderate (40-79), High (80-119), and Very High (120-160).

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Cohen's weighted kappa
Lasso di tempo: Baseline (single study visit)
The primary outcome is Cohen's weighted kappa (κw) with quadratic weights, computed between DCRQ and CAMBRA 4-level classifications (Low / Moderate / High / Very High). Both instruments share a 4-tier structure; no category collapsing is required. Minimum acceptable agreement: κw ≥ 0.41 (lower bound of 95% CI), corresponding to moderate agreement per Landis and Koch (1977). The 95% CI will be computed by bootstrap resampling (2,000 iterations).
Baseline (single study visit)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Diagnostic accuracy of the Digital Caries Risk Questionnaire (DCRQ) for identifying participants with high cumulative caries experience (DMFT ≥ 4).
Lasso di tempo: Baseline (single study visit)
Diagnostic accuracy will be evaluated by calculating sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) using DMFT ≥ 4 as the reference standard.
Baseline (single study visit)
Discriminative ability of the DCRQ for identifying participants with high cumulative caries experience.
Lasso di tempo: Baseline (single study visit)
Receiver operating characteristic (ROC) curve analysis will be performed to determine the area under the curve (AUC) and the optimal DCRQ score cut-off for predicting DMFT ≥ 4.
Baseline (single study visit)
Independent predictors of high cumulative caries experience.
Lasso di tempo: Baseline (single study visit)
Multivariable logistic regression will be used to identify independent predictors of DMFT ≥ 4 and estimate the contribution of each DCRQ domain after adjustment for relevant covariates.
Baseline (single study visit)
Internal consistency of the DCRQ.
Lasso di tempo: Baseline (single study visit)
Internal consistency reliability will be assessed using Cronbach's alpha coefficient.
Baseline (single study visit)
Test-retest reliability of the DCRQ.
Lasso di tempo: 14 days after baseline
Test-retest reliability will be assessed using the intraclass correlation coefficient (ICC) in a nested subset of 60 participants who complete the DCRQ on two occasions separated by a 14-day interval.
14 days after baseline
Performance of the DCRQ across participant subgroups.
Lasso di tempo: Baseline (single study visit)
Diagnostic performance and agreement of the DCRQ will be evaluated according to age, sex, educational level, and smoking status.
Baseline (single study visit)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

5 giugno 2026

Completamento primario (Stimato)

1 ottobre 2026

Completamento dello studio (Stimato)

1 novembre 2026

Date di iscrizione allo studio

Primo inviato

9 luglio 2026

Primo inviato che soddisfa i criteri di controllo qualità

15 luglio 2026

Primo Inserito (Effettivo)

21 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

21 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

15 luglio 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi